Literature DB >> 564390

Mouse spleen lymphoblasts generated in vitro. Their replication and differentiation in vitro.

R M Steinman, S J Blumencranz, B G Machtinger, J Fried, Z A Cohn.   

Abstract

Mouse spleen lymphoblasts induced with lipopolysaccharide and fetal calf serum were obtained in high yield and purity in their first proliferative cell cycle by floatation in dense bovine plasma albumin columns (3). The blasts were maintained in vitro for 3 more days. The cultures were examined in bulk on each day, and in addition, those cells in S phase initially were tagged with [(3)H]thymidine and followed continuously in vitro. Grain count dilution data indicated that most blasts divided but twice over a 2- to 3-day interval in vitro. [(3)H]Thymidine pulse radiolabeling and flow microfluorometry suggested that at least 50-70 percent of the proliferating blasts withdrew from proliferative activity after 2-3 days of culture. Morphologic studies demonstrated that lymphoblasts persisted as such for 1-2 days in vitro and then matured into typical plasma cells. Many of the blastprogeny had small nuclei and considerable basophilic cytoplasm on Giemsa-stained cell smears; abundant rough endoplasmic reticulum by electron microscopy; and readily detectable cytoplasmic Ig by immunocytochemistry. Reversion of blasts to small lymphocytes could not be detected; however, some blasts persisted even after 3 days of culture. The viability of the cultured lymphoblast was followed by initially tagging the cells with [(3)H]thymidine as well as several other techniques. Little cell death was documented during the first day of culture. The number of labeled progeny increased twofold whereas the grain count halved. But 40- 50 percent of the cell-associated label was lost during each of the second and third days, and fewer labeled progeny than predicted by grain count dilution were identified. The culture medium could not be implicated in this loss of lymphoblast progeny, and we suggest that the maturation of the lymphoblast to a short-lived plasma cell was responsible. Therefore mitogen-stimulated B blasts seem to mature into typical plasma cells after just two cycles of cell division. The plasma cells resemble those produced in situ during an immune response in their cytologic features, withdrawal from active proliferative activity, and short life-span.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 564390      PMCID: PMC2184482          DOI: 10.1084/jem.147.2.297

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  31 in total

1.  MORPHOLOGICAL AND KINETIC STUDIES ON ANTIBODY-PRODUCING CELLS IN RAT LYMPH NODES.

Authors:  B M BALFOUR; E H COOPER; E L ALPEN
Journal:  Immunology       Date:  1965-03       Impact factor: 7.397

2.  THE FINE STRUCTURE OF THE LYMPHOID TISSUE DURING ANTIBODY FORMATION.

Authors:  H Z MOVAT; N V FERNANDO
Journal:  Exp Mol Pathol       Date:  1965-04       Impact factor: 3.362

3.  Ultrastructure of lymphoid and plasma cells in realtion to globulin and antibody formation.

Authors:  M C BESSIS
Journal:  Lab Invest       Date:  1961 Nov-Dec       Impact factor: 5.662

4.  Production of lymphocytes and plasma cells in the rat following immunization with human serum albumin.

Authors:  E H COOPER
Journal:  Immunology       Date:  1961-07       Impact factor: 7.397

5.  Autoradiographic observations of plasma cell formation.

Authors:  J C SCHOOLEY
Journal:  J Immunol       Date:  1961-03       Impact factor: 5.422

6.  Quantitative studies on the precursors of cytotoxic lymphocytes. I. Characterization of a clonal assay and determination of the size of clones derived from single precursors.

Authors:  H S Teh; E Harley; R A Phillips; R G Miller
Journal:  J Immunol       Date:  1977-03       Impact factor: 5.422

7.  The in vivo reutilization of lymphocytic and sarcoma DNA by cells growing in the peritoneal cavity.

Authors:  W O RIEKE
Journal:  J Cell Biol       Date:  1962-05       Impact factor: 10.539

8.  Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors.

Authors:  K F Lindahl; D B Wilson
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

9.  Studies on antibody production. II. The primary and secondary responses in the popliteal lymph node of the rabbit.

Authors:  E H LEDUC; A H COONS; J M CONNOLLY
Journal:  J Exp Med       Date:  1955-07-01       Impact factor: 14.307

10.  Autoradiographic studies on the immune response.I. The kinetics of plasma cell proliferation.

Authors:  G J NOSSAL; O MAKELA
Journal:  J Exp Med       Date:  1962-01-01       Impact factor: 14.307

View more
  6 in total

1.  cGAS-mediated control of blood-stage malaria promotes Plasmodium-specific germinal center responses.

Authors:  William O Hahn; Noah S Butler; Scott E Lindner; Holly M Akilesh; D Noah Sather; Stefan Hi Kappe; Jessica A Hamerman; Michael Gale; W Conrad Liles; Marion Pepper
Journal:  JCI Insight       Date:  2018-01-25

2.  A System for In Vitro Generation of Mature Murine Plasma Cells Uncovers Differential Blimp-1/Prdm1 Promoter Usage.

Authors:  Emily Robinson; Matthew A Care; Kieran Walker; Michelle Campbell; Reuben M Tooze; Gina M Doody
Journal:  J Immunol       Date:  2021-12-15       Impact factor: 5.422

3.  Lymphoid dendritic cells are potent stimulators of the primary mixed leukocyte reaction in mice.

Authors:  R M Steinman; M D Witmer
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

Review 4.  Immunological memories of the bone marrow.

Authors:  Hyun-Dong Chang; Koji Tokoyoda; Andreas Radbruch
Journal:  Immunol Rev       Date:  2018-05       Impact factor: 12.988

5.  Products of the IgT-C region of chromosome 12 are maturational markers for T cells. Sequence of appearance in immunocompetent T cells parallels ontogenetic appearance of Tthyd, Tindd, and Tsud.

Authors:  F L Owen
Journal:  J Exp Med       Date:  1982-09-01       Impact factor: 14.307

6.  Zanvil Alexander Cohn 1926-1993.

Authors:  R M Steinman; C L Moberg
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.